BAY-55-9837 TFA

BAY-55-9837 TFA

Cat. No.: DIA-0231190

Size: 100 mg Size: 500 mg Size: Customer Size
Product Information
CAS No. 463930-25-8
Formula C150H240F3ClN44O44
Molecular Weight 3456.22
Product Description Bay 55-9837 TFA is a potent and highly selective agonist of VPAC2, with a Kd of 0.65 nM. Bay 55-9837 TFA may be a useful therapy for the research of type 2 diabetes.
Format & Storage
Format Solid
Purity > 99%
Shipping Shipped on dry ice.
Storage Protect from light. Powder: -80 °C, 2 years; -20 °C, 1 year. In solvent: -80 °C, 6 months; -20 °C, 1 month (protect from light).
Solubility Overview Soluble in DMSO
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top